Unlike Pinealon and Epitalon, which primarily target the pineal gland, DSIP is produced in the hypothalamus and works through a broader range of neurological pathways
Combining nanoplatforms with ICIs, epigenetic modulators, or targeted therapies could create layered treatment ecosystems capable of outmaneuvering tumor evolution
Published research on these studies documented outcomes from approximately 900 adult participants, predominantly individuals classified as clinically obese, though one trial included healthy non-obese volunteers
Its designed to discourage athletes from even approaching the gray areas
Promotes a brighter and more even skin tone
Disease Management and Clinical Outcomes, 1(4), 136-141